Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Change in Interest Receivables (2016 - 2017)

Historic Change in Interest Receivables for Silo Pharma (SILO) over the last 4 years, with Q3 2017 value amounting to $34222.0.

  • Silo Pharma's Change in Interest Receivables rose 40419.56% to $34222.0 in Q3 2017 from the same period last year, while for Dec 2017 it was $20361.0, marking a year-over-year increase of 14547.2%. This contributed to the annual value of $20361.0 for FY2017, which is 14547.2% up from last year.
  • Per Silo Pharma's latest filing, its Change in Interest Receivables stood at $34222.0 for Q3 2017, which was up 40419.56% from -$6500.0 recorded in Q2 2017.
  • Over the past 5 years, Silo Pharma's Change in Interest Receivables peaked at $34222.0 during Q3 2017, and registered a low of -$12500.0 during Q1 2016.
  • Over the past 4 years, Silo Pharma's median Change in Interest Receivables value was -$5383.5 (recorded in 2015), while the average stood at -$2838.5.
  • Per our database at Business Quant, Silo Pharma's Change in Interest Receivables tumbled by 120753.14% in 2016 and then surged by 40419.56% in 2017.
  • Quarter analysis of 4 years shows Silo Pharma's Change in Interest Receivables stood at -$2379.0 in 2014, then crashed by 191.42% to -$6933.0 in 2015, then dropped by 29.81% to -$9000.0 in 2016, then soared by 480.24% to $34222.0 in 2017.
  • Its Change in Interest Receivables was $34222.0 in Q3 2017, compared to -$6500.0 in Q2 2017 and -$7361.0 in Q1 2017.